Yiheng Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-554,151	Closed	-$17.7M	–	24
2023 Q3	$17.7M	Hold	554,151	–	–	0.9%	16
2023 Q2	$22.3M	Hold	554,151	–	–	1.2%	15
2023 Q1	$23.7M	Buy	+554,151	New	+$23.7M	0.94%	15